Accendra HealthACH +3.64%57 Forward PE Ratio is 3.52 as of Jul. 11, 2026. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.46 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 51 Medical Distribution companies, Accendra Health ranks better than 94.12% on this metric.
Accendra Health (NYSE:ACH) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Accendra Health Forward PE Ratio Related Terms
Accendra Health Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Accendra Health's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accendra Health Forward PE Ratio Chart
Accendra Health Annual Data
Trend
2015-12
2016-12
2017-12
2018-12
2019-12
2020-12
2021-12
2022-12
2023-12
2024-12
2025-12
Forward PE Ratio
17.64
17.73
8.93
7.40
6.09
9.81
12.77
7.81
10.11
6.97
2.85
Accendra Health Quarterly Data
2015-12
2016-03
2016-06
2016-09
2016-12
2017-03
2017-06
2017-09
2017-12
2018-03
2018-06
2018-09
2018-12
2019-03
2019-06
2019-09
2019-12
2020-03
2020-06
2020-09
2020-12
2021-03
2021-06
2021-09
2021-12
2022-03
2022-06
2022-09
2022-12
2023-03
2023-06
2023-09
2023-12
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
17.64
17.76
18.05
17.36
17.73
18.15
17.61
13.55
8.93
7.83
8.87
11.98
7.40
5.77
4.91
6.35
6.09
9.81
14.73
16.37
9.81
11.63
12.39
9.96
12.77
13.18
9.86
6.86
7.81
11.06
14.81
7.41
10.11
18.28
8.69
7.93
6.97
4.91
5.35
4.84
2.85
2.15
ACH vs FOCL, YI, COSM: Forward PE Ratio Comparison
For the Medical Distribution subindustry, Accendra Health's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accendra Health Forward PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Accendra Health's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Accendra Health's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Accendra Health (ACH) has a Forward PE Ratio of 3.52 as of Jul. 11, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Accendra Health and its competitors. According to the industry distribution chart, Accendra Health ranks #3 out of 51 companies in the Medical Distribution industry, placing it in the top 5.9%.
Is Accendra Health's Forward PE Ratio too high?
Accendra Health's current Forward PE Ratio is 3.52. The Medical Distribution industry median Forward PE Ratio is 14.57. Accendra Health's value of 3.52 is 75.8% below this industry median. Based on the distribution chart, Accendra Health ranks #3 out of 51 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Forward PE Ratio compare to FOCL and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #3 out of 51 companies for Forward PE Ratio. This places Accendra Health in the top 6% of its industry — outperforming the majority of peers. The industry median Forward PE Ratio is 14.57. Accendra Health's value of 3.52 is 75.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 14.57, based on 51 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current Forward PE Ratio of 3.52 is 75.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 14.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current Forward PE Ratio is 3.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.46, compared to a current price of $3.42 — trading 37.4% below its estimated fair value. The current Forward PE Ratio is 3.52 and 75.8% below the Medical Distribution industry median of 14.57. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Accendra Health (ACH), the current Forward PE Ratio is 3.52 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Accendra Health (ACH) Overvalued in 2026?
Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued.
The current stock price of $3.42 is trading 37.4% below its estimated GF Value™ of $5.46.
GuruFocus considers Accendra Health to be Possible Value Trap.
Key valuation signals for ACH:
Forward PE Ratio: 3.52
GF Value™: $5.46 vs. price of $3.42 (37.4% below fair value)
Industry Position: 75.8% below the Medical Distribution median (#3 of 51)
No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score
Get the complete analysis for ACH
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ACH has been successfully added to your 